My Medication Side Effects Are Too Popular

Let Pfizer understand that the market value of [-] billion is also false, and it may decrease a lot at any time!

PS: Ask for flowers, ask for evaluation, ask for automatic subscription!!!

Chapter [-]: Everything is ready, the show begins!

Pfizer has been stumbling on Xinming Pharmaceutical before, and has led many pharmaceutical companies to target Xinming Pharmaceutical

Competition between peers is common, but Pfizer is still using some disgusting tricks when it knows that it will not be able to completely defeat Xinming Pharmaceuticals

This is intentional.

From Pfizer's point of view, they don't want to give up the No. [-] throne, they can continue to develop better medicines, develop other medical devices, and develop nutrition

Health supplements or something.

There is no need to compete with Xinming Pharmaceutical in the pharmaceutical market. After all, everyone can see the prospect of Xinming Pharmaceutical's new drugs.

However, Pfizer chose to suppress Xinming Pharmaceutical, and also tried to cooperate with other top pharmaceutical companies to completely block Xinming Pharmaceutical from the eastern market and prevent it from entering the European market.

sheep market

For this reason, Xinming Pharmaceutical has paid more funds for publicity and channels.

This means that the Fu family has less money to share. How can Fu Liang bear it?

It may not be possible to defeat Pfizer all at once, at least not within a year or two. After all, it takes time for many drugs to come to market.

But he can let Pfizer suffer first, and make a fortune by the way,

Fu Liang invested a billion dollars in the Pearl, which is the Asian financial center, one of the four major financial centers in the world, and has many financial companies.

Through several financial companies, with twenty times leverage, shorted Pfizer's stock.

As long as Pfizer's stock rises by [-]%, Fu Liang's money will be wiped out.

After Pfizer's third-quarter financial report was announced, it rose for three consecutive days, with a total increase of more than [-]%, which stabilized

For a company of the size of Pfizer, it is not easy to increase by [-]% with a market value of [-] billion yuan, and the capital required is not a small amount.

Being able to rise by [-]% has already increased Pfizer's market value by more than $[-] billion again.

Pfizer's shareholders are very satisfied with this. Although Johnson & Johnson's stock price is also rising, and it has exceeded [-] billion US dollars, they are still trampled by them!

Fu Liang came to Mingzhu again and contacted Citibank here. The other party was willing to give him a loan, as long as he took some valuable things to pay off

When I came to the big customer room of the bank, the president of the bank, Kendall, came directly

"Mr. Fu, we have done an evaluation. Although many people say that your laboratory is worth tens of billions of dollars or more, after all, the drugs before the laboratory are worth tens of billions of dollars or more.

Fangdu was sold to Xinming Pharma

"But you are in the laboratory, so we are still willing to lend you a loan, but you need to pledge other shares in your hand.

"For example, the shares you hold in Xinming Pharmaceutical Co., Ltd., Xinmei Cosmetics Co., Ltd., and Xinqiang Pharmaceutical Co., Ltd., a joint venture with Johnson & Johnson, are not

"But it's just a laboratory with a patent for a new specific drug, and we can only loan you two hundred million dollars, also because that's your laboratory.

Fu Liang was not surprised by this: "Okay, tell me, how much can I loan the shares of Xinming Pharmaceutical Co., Ltd. and Xinmei Cosmetics Co., Ltd. that I hold?

This time, he is absolutely sure that it will be high, and Sun also has Mingzhu who has found a partner. As long as the other party sees an opportunity, they will follow the trend and sell short Pfizer shares.

So a month or so, he can make double, or even more profit!

Of course, you can borrow as much as you can.

"Xinmei Cosmetics Co., Ltd. has two new cosmetic products that have not yet been listed, and the market evaluation potential is full. We can also give you the goods you hold.

two million dollars.

"As for the shares of Xinming Pharmaceutical, you don't hold much, and you can only borrow $[-] million.

"For the shares of Xinqiang Pharmaceutical Company, we can lend you five hundred million dollars.

A total of one billion dollars, this money should be enough to pay Mr.

Of course, Kendall has to personally receive a major customer with a payment of one billion dollars, and he also hopes to be able to secure it.

Fu Liang took out another document: "This is the document authorized by my parents, can I use the shares they hold to take out a loan?

Kendall took a closer look: "It's fine in theory, but it's complicated. It's better for them to come over and sign in person.

We can talk first.

"The shares of Xinming Pharmaceutical and Xinqiang Pharmaceutical that they hold, I can lend you three billion dollars.

"Mr. Fu, I know that the shares of those companies are sold, and there must be more than this amount of money, but we need to examine tiger risks.

"And I guarantee that we will release the loan the fastest. As long as you sign, you can release the loan on the same day. No other bank can promise you this.

Four billion dollars?enough.

Fu Diantian nodded: "Yes, but I also have conditions. The loan is one month, and the principal and interest are repaid in one month. If the repayment is made early, it will be calculated on a daily basis.

interest.

Only for a month?

Kendall has some regrets, what product is this to invest in?

The interest rate is not very high for a month.

Moreover, the repayment in advance, and the interest calculated on a daily basis, then their income will be much less.

Mr. Fu, if you have this condition, then the interest may be slightly higher. After all, if you repay in advance, we will not earn much.

The next day, Fu Liang's parents also flew to Mingzhu's side. After signing the signature, Fu Xinming patted Fu Liang's shoulder: "Son, your handwriting is quite big this time.

If it's really a loss, we don't blame you.

"I still have some cash in my bank account, we're sure enough to retire, you're going to start all over again.

Fu Liang looked at Fu Xinming with a smile: "Dad, don't worry, our family will be on the list next year's list of the richest people in China!

The parents left after playing with Mingzhu for two days, and Fu Liang stayed here.

He put $[-] billion back into the financial markets, shorting Pfizer stock.

Wall Street and many financial companies around the world have noticed this situation. This unusual investment will always attract people's attention.

Analyze the possibility of profit here.

However, the analysis of Pfizer's stock price has not been analyzed, but the possibility of Pfizer's share price falling has not been analyzed, but it has turned Pfizer into a stock to focus on.

At this time, Fu Liang received a call from Zhou Yongquan.

"Xiao Fu, the Phase II clinical trial of that thrombosis drug has ended, and the effect is very successful!

'You can apply for clinical trials abroad at the same time, and I am also ready for the third phase in China. "

A look of joy appeared on Fu Liang's face, and the good news finally came.

"Mr. Zhou, please publish the Phase II clinical data of this thrombosis drug and tell the media that this is a new type of thrombosis drug that will replace xaban drugs.

The toxic and side effects are smaller than those of the saban class, and the effect is more prominent!

After hanging up the phone, Fu Liang looked at the huge amount of people outside the window: "Pfizer's shareholders, the show is about to begin!

PS: Ask for flowers, ask for evaluation, ask for automatic subscription!!!.

Chapter [-]: Thrombosis drug shock announcement, Pfizer stock price falls

The directors of Pfizer are sitting together again, because they found that yesterday in the Pearl of the East, billions of dollars have been invested in the financial market.

Short their Pfizer stock.

That adds up to five billion dollars, and that's not a lot of money for the average person.

This can't be done by the Fu family. Where does the Fu family have so much money?

The Fu family is not a big family in the East, not even a big family in Bingcheng at this time last year.

It is only because of the continuous emergence of new drugs this year that the Fu family's assets continue to rise, but most of them are the company's shares, and the Fu family will not be stupid at this time.

Lucky to lose company shares.

This money cannot be all paid to the family, that is because other financial institutions are planning to short their Pfizer?

"Dear directors, five billion dollars in funds is not a small amount. If other financial institutions enter the market at this time, or some international tourism

capital, we Pfizer's stock price will definitely fall, and the loss is all of us

Many directors may not be major shareholders of the company, with only about one percent of the stock, but that represents a net worth of two billion dollars,

If it drops by [-] percent, it's a loss of $[-] million.

A loss of two hundred million dollars, which 377 people will feel distressed.

"But I don't see the possibility of our Pfizer share price falling, those financial giants are suppressing our stock at this time, paying

A director spreads his hands:

The consultation is definitely not a small number

"Such a large sum of money is enough to leverage the stocks of other companies, so why target us Pfizer? When our Pfizer shareholders have no money to fight back

Abel took a cigar: "It is of course difficult to spend money directly, if there is any major negative news about our company, it doesn't need those big institutions.

Smashing the market and the continuous selling of retail investors can make our stock price fall rapidly!

"Everyone should think about whether there are any loopholes in the company's operations recently that can be caught.

All the directors have thought that there is no problem with the operation of the company.

Recently, their medicines are selling very well, and there are no major lawsuits. The medical equipment companies they invest in are also progressing well.

The current US policy is also very good for them, it does not seem to have a major impact.